BY INTRAVITREAL INJECTION, INITIALLY 500 MICROGRAMS ONCE A MONTH FOR 3 MONTHS INTO THE AFFECTED EYE, THEREAFTER MONITOR VISUAL ACUITY ONCE A MONTH; IF NECESSARY SUBSEQUENT DOSES MAY BE GIVEN AT LEAST 1 MONTH APART .
IN THE NINE MONTHS AFTER 3 INITIAL MONTHLY DOSES, LESS FREQUENT DOSING WITH 4-5 DOSES ON AVERAGE IS EXPECTED TO MAINTAIN VISUAL ACUITY WHILE MONTHLY DOSING MAY BE EXPECTED TO RESULT IN AN ADDITIONAL AVERAGE 1-2 LETTER GAIN.